pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,950 catalysts · 4,970 phase readout · 2,360 8k filing · 287 earnings · 278 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 31 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout4,970
  • 8k filing2,360
  • earnings287
  • pdufa278
  • phase 2 completion129
  • phase 1 completion61
  • phase 1 initiation32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Oncology107
    • Cardiology29
    • Infectious Disease29
    • Immunology21
    • Dermatology15
    • Pulmonology14
    • Women's Health10
    • Ophthalmology10
    • Pain8

    Date TBD

    50
    ›RECRUITINGphase readoutNCT04864886: Metabolic Profiling of Immune Responses in Immune-mediated Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Primary Immunodeficiency, Psoriasis, Atopic Dermatitis, Immune-mediated Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07447570: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07326670: Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL

    Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Anesthesia Techniques, Percutaneous Nephrolithotomy, Systemic Inflammation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06991270: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

    Sponsor: Sight Sciences, Inc.. Phase: NA. Conditions: Primary Open Angle Glaucoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06397573: Ablative Stereotactic MR-Guided Adaptive Reirradiation

    Sponsor: Baptist Health South Florida. Phase: NA. Conditions: Abdominal Cancer, Pelvic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05010473: Cortical Contributions to Frequency Following Responses and Modulation

    Sponsor: Northwestern University. Phase: NA. Conditions: Language

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06609473: Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Childhood Cancer, Childhood Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05411341: Comparison of Two Different Optical Biometric Systems

    Sponsor: Democritus University of Thrace. Phase: . Conditions: Cataract, Presbyopia, Ocular Biometry, Intraocular Lens

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01580241: Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

    Sponsor: University of Oklahoma. Phase: . Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07225283: Developing Resiliency and Exercise Using AI-based Messaging

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Diabetes Mellitus Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506954: Impact of Sound Shower Music Diffusion on Family Anxiety in Intensive Care Unit Waiting Room

    Sponsor: University Hospital, Tours. Phase: NA. Conditions: Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06588166: Microbiome Testing for the Screening of Colorectal Cancer

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07477366: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

    Sponsor: ImmunityBio, Inc.. Phase: PHASE2. Conditions: Relapsed B-Cell Non-Hodgkin Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03438994: Early Assessment of Autism Through Smart Tablet Gameplay

    Sponsor: University of Strathclyde. Phase: NA. Conditions: Autism Spectrum Disorder, Other Neurodevelopmental Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07518966: Association Between Early Recurrence and Long-Term Recurrence After Pulsed Field Ablation for Atrial Fibrillation: Prospective Real-World Evidence From China

    Sponsor: West China Hospital. Phase: . Conditions: Atrial Fibrillation (AF)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07226817: A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07426640: Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

    Sponsor: Al Mouwasat Hospital. Phase: NA. Conditions: Premature (Early) Ejaculation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01675440: Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

    Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Severe Aortic Stenosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854640: A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

    Sponsor: Bayer. Phase: PHASE1. Conditions: Sepsis, Coagulopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05261750: Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

    Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Nasopharyngeal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03971591: Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

    Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05766891: Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06455774: The Wearable Postural Feedback Devices Combined With Exercise in Office Workers With Chronic Neck Pain

    Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Neck Pain

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07161518: Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation

    Sponsor: Stanford University. Phase: PHASE4. Conditions: Healthy Participants

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07264790: Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

    Sponsor: Duke University. Phase: PHASE1. Conditions: Breast Reconstruction, Perfusion; Complications, High Risk for Breast Cancer, Genetic Predisposition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

    Sponsor: University of Manitoba. Phase: PHASE3. Conditions: Community-acquired Pneumonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03839459: Denosumab for Smoldering Multiple Myeloma

    Sponsor: University of Rochester. Phase: PHASE2. Conditions: Smoldering Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05651880: Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

    Sponsor: University Hospital, Rouen. Phase: PHASE3. Conditions: Active Non-anterior Non-infectious Uveitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07431879: Acute Muscle Damage After Eccentric Quasi-Isometric Exercise of the Elbow Flexors

    Sponsor: Chinese Culture University. Phase: NA. Conditions: Acute Muscle Damage Following Resistance Exercise

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06519162: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

    Sponsor: Chungnam National University Hospital. Phase: . Conditions: Autoimmune Hepatitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Liver Abscess, Primary Biliary Cirrhosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04810546: Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Iron-deficiency, Pregnancy Anemia, Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07062588: Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

    Sponsor: Angitia Incorporated Limited. Phase: PHASE2. Conditions: Osteogenesis Imperfecta (OI)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07503288: Genotype and Subtype Mapping of the Hepatitis C Virus

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Hepatitis C Virus, Mutation Abnormality, RNA Positive, Unusual Subtype, Resistance

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07427888: Treatment of Cancer Pain Using an Implantable Intrathecal Pump

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Cancer Pain, Neoplasm-Related Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07069127: Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients

    Sponsor: University of Pavia. Phase: NA. Conditions: Celiac Disease, Dentin Hypersensitivity, Tooth Demineralization

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04977427: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

    Sponsor: Baylor Research Institute. Phase: PHASE4. Conditions: Cataract Diabetic, Macula Edema

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07548970: Identification and Characterization of At-risk MASLD in Turkish Adults

    Sponsor: Maastricht University Medical Center. Phase: . Conditions: MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Mediterranean Diet, Lifestyle (Sedentary Behavior and Physical Activity), Vitamin D Deficiency, Hyperuricemia and MAFLD, Ferritin

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03621670: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

    Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Infections, Meningococcal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06653673: The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses

    Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Overweight (BMI > 25), Obesity and Overweight, Emotional Eating, Binge Eating

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07507669: Impact of MetaCalm on Stress of Healthy People With Acute Stress

    Sponsor: Metagenics, Inc.. Phase: NA. Conditions: Adults, Acute Stress Reaction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497569: Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: GastroEsophageal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06801483: Ankle Strengthening in Athletes With Chronic Ankle Instability

    Sponsor: China Medical University Hospital. Phase: NA. Conditions: Chronic Ankle Instability, CAI, Athletes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05465941: PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

    Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06799741: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

    Sponsor: AbViro LLC. Phase: PHASE2. Conditions: DENV-3 Controlled Human Infection Model

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06638541: Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

    Sponsor: Royal Marsden NHS Foundation Trust. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07388641: Improving Productive Community Integration in Homeless-experienced Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Homeless Persons

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506941: Study of Functional Decline and Care Pathways in Neurosurgical Patients Over 65 Years of Age

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Ageing and Geriatric Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06238141: Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns

    Sponsor: Changzhi Medical College. Phase: NA. Conditions: Stress, Psychological

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05148325: Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

    Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Advanced Solid Tumor, Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06423625: Hemorrhagic MI Prediction Score Model

    Sponsor: Rohan Dharmakumar. Phase: . Conditions: Acute Myocardial Infarction

    full page →ctgov ↗
    ← prev
    page 67 of 159
    next →